Scfv abvance: increasing our knowledge of antibody structural space to enable faster and better decision making in drug discovery

Grouped By: Sequence identity 90%

Group Content:

Group Members:

Release Date:

Structure Features

Sequence Features

Experimental Features

Organisms

Protein Domains

Function

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.